Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,131 | 23,850 | 47,987 | 32,908 | 11,534 |
| Marketable Securities | N/A | N/A | N/A | 2,678 | N/A |
| Receivables | N/A | N/A | 3,683 | N/A | N/A |
| Inventories | N/A | N/A | 386 | N/A | N/A |
| Other current assets | 22,092 | 27,013 | 0 | 0 | 0 |
| TOTAL | $53,621 | $52,100 | $53,455 | $36,121 | $11,810 |
| Non-Current Assets | |||||
| PPE Net | 335 | 285 | 665 | 29 | 393 |
| Intangibles | 15,153 | 15,152 | 20,877 | 5,898 | 5,898 |
| Other Non-Current Assets | 13,035 | 12,951 | 12,979 | 12,938 | 12,867 |
| TOTAL | $28,523 | $28,388 | $34,521 | $18,865 | $19,158 |
| Total Assets | $82,144 | $80,488 | $87,976 | $54,986 | $30,968 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,739 | 3,910 | 2,149 | N/A | N/A |
| Accounts payable and accrued liabilities | 26,597 | 1,886 | 2,660 | 1,976 | 2,155 |
| Accrued Expenses | 5,292 | 8,885 | 8,699 | 2,038 | 2,168 |
| Other current liabilities | 14,518 | 5,383 | 48,965 | 11,899 | 5,528 |
| TOTAL | $57,071 | $27,233 | $62,473 | $15,919 | $11,202 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 4,492 | 7,743 | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | N/A | 816 |
| Other Non-Current Liabilities | 6,142 | 6,651 | 6,821 | 6,207 | 4,569 |
| TOTAL | $11,560 | $16,196 | $19,617 | $11,311 | $9,654 |
| Total Liabilities | $68,631 | $43,429 | $82,090 | $27,230 | $20,856 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6 | 4 | 4 | 3 | N/A |
| Common Shares | 15 | 12 | 10 | 8 | 5 |
| Retained earnings | -279,383 | -215,481 | -178,875 | -102,197 | -67,228 |
| Other shareholders' equity | 151 | 151 | 151 | 1,777 | 151 |
| TOTAL | $13,513 | $37,059 | $5,886 | $27,756 | $10,112 |
| Total Liabilities And Equity | $82,144 | $80,488 | $87,976 | $54,986 | $30,968 |